The Portal drug delivery technology is needle-free, fast and computer-controlled. It automatically adjusts the injection velocity up to one thousand times in the half-second it takes to completely deliver a 1 ml dose. The result is the precise administration of high viscosity biologic drugs through the skin, via an extremely collimated jet, the size of a strand of hair. HIPPA-compliant, automatic collection and transfer of injection and health data sets a new standard of engagement between the care team and the patient. With a clear view of patient behavior, protocols can be better managed, research is better informed and compliance is improved.
Portal Instruments, a clinical stage medical device start-up company based in Cambridge, MA received the SXSW Interactive Innovation Award in the Health, Med & Biotech category at the 20th annual South by Southwest (SXSW) Interactive Innovations Awards ceremony. The award was in recognition of Portal Instruments’ ground-breaking work in the development of an innovative, needle-free drug delivery platform to transform the administration of high viscosity biologics and enhance the patient experience for chronic disease management. Known for celebrating the most inspiring, creative advancements of the year, the SXSW Interactive Innovation Award recognized Portal’s needle-free drug delivery platform as “the new technology that best improves the quality, efficacy, and cost-effectiveness of prevention, diagnosis, treatment and care in health and medicine.”